Lucina
acquired by Unified Womens HealthcareSanta Cruz, US · 1 known investors
Lucina Biotherapeutics develops therapeutics to treat aging-related disorders, particularly dry age-related macular degeneration (AMD), by restoring very long-chain polyunsaturated fatty acids (VLC-PUFAs) in tissues through its PUFActive platform. The company employs two approaches: synthetic VLC-PUFA formulations for intravitreal injection and engineered microorganism biofactories for oral delivery.
BiotechLongevityMedical Devices
Founders & leadership
CC
Christopher ChavezCo-Founder and Chief Executive Officer
DS
Dorota Skowronska-KrawczykScientific Co-Founder
ME
Marty Emanuele
J
Jeanette
D
David
Investors · 1
In the news
- Lucina Health acquired by Unified Women's Healthcare LLC - Louisville Business Firstbizjournals.com · 2020